Capitol Health Future Growth

Future criteria checks 4/6

Capitol Health is forecast to grow earnings and revenue by 68.4% and 6.4% per annum respectively. EPS is expected to grow by 68.5% per annum. Return on equity is forecast to be 15.1% in 3 years.

Key information

68.4%

Earnings growth rate

68.5%

EPS growth rate

Healthcare earnings growth	25.2%
Revenue growth rate	6.4%
Future return on equity	15.1%
Analyst coverage	Good
Last updated	17 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CHIA:CAJ - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2027	284	19	21	50	7
6/30/2026	270	15	19	45	8
6/30/2025	252	13	15	39	8
6/30/2024	235	-15	17	36	N/A
3/31/2024	232	-5	14	36	N/A
12/31/2023	229	6	12	36	N/A
9/30/2023	219	-3	16	37	N/A
6/30/2023	210	-12	21	37	N/A
3/31/2023	198	-12	18	33	N/A
12/31/2022	187	-12	16	28	N/A
9/30/2022	186	-1	18	30	N/A
6/30/2022	184	11	19	32	N/A
3/31/2022	186	12	22	34	N/A
12/31/2021	188	14	26	36	N/A
9/30/2021	183	13	29	39	N/A
6/30/2021	178	12	33	41	N/A
3/31/2021	168	8	33	43	N/A
12/31/2020	159	4	34	45	N/A
9/30/2020	156	3	28	40	N/A
6/30/2020	154	1	23	35	N/A
3/31/2020	156	8	18	30	N/A
12/31/2019	157	15	12	25	N/A
9/30/2019	153	20	8	22	N/A
6/30/2019	149	24	4	18	N/A
12/31/2018	137	-2	5	15	N/A
9/30/2018	128	-6	4	13	N/A
6/30/2018	119	-11	4	11	N/A
12/31/2017	110	2	N/A	15	N/A
9/30/2017	108	2	N/A	15	N/A
6/30/2017	107	2	N/A	15	N/A
12/31/2016	80	1	N/A	13	N/A
9/30/2016	92	2	N/A	13	N/A
6/30/2016	104	2	N/A	13	N/A
3/31/2016	148	-2	N/A	15	N/A
12/31/2015	139	1	N/A	13	N/A
9/30/2015	125	3	N/A	14	N/A
6/30/2015	110	4	N/A	16	N/A
3/31/2015	103	6	N/A	16	N/A
12/31/2014	95	9	N/A	16	N/A
9/30/2014	92	8	N/A	14	N/A
6/30/2014	90	7	N/A	12	N/A
3/31/2014	83	6	N/A	10	N/A
12/31/2013	77	5	N/A	7	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CAJ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: CAJ is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: CAJ is expected to become profitable in the next 3 years.

Revenue vs Market: CAJ's revenue (6.4% per year) is forecast to grow faster than the Australian market (5.7% per year).

High Growth Revenue: CAJ's revenue (6.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CAJ's Return on Equity is forecast to be low in 3 years time (15.1%).

Capitol Health Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Recent updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Now 21% undervalued after recent price drop

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 25% undervalued after recent price drop

Now 20% undervalued after recent price drop

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings released: AU$0.011 loss per share (vs AU$0.01 profit in FY 2022)

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.008 profit in 1H 2022)

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings released: EPS: AU$0.01 (vs AU$0.012 in FY 2021)

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

New 90-day high: AU$0.30

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

New 90-day high: AU$0.27

Capitol Health Limited (ASX:CAJ) completed the acquisition of 90% stake in Fowler Simmons Radiology.

Capitol Health Limited to Report Fiscal Year 2020 Results on Aug 26, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies